Latest News
2 Medical-Device Stocks Lighting Up the Options Pits
Medical-device stocks Cooper Companies Inc (NASDAQ:COO) and Axogen Inc (NASDAQ:AXGN) are both sharply lower following separate company developments, and options traders are chiming in.
The World Is Taking Notice: TIME Recognition Fuels VinFast's Global Journey
On a rainy Tuesday morning in Paris, a driver waiting at a red light on Boulevard Haussmann might not immediately place the badge on the SUV beside them. Thousands of miles away, a driver in Californi
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN).
CoreWeave's Massive Backlog Signals Buying Opportunity
CoreWeave Corporation (CRWV) remains a 'Buy' as I see the market underestimating its execution quality and future growth potential. CRWV's backlog surged from $15B in fiscal 2025 to $104.2B in Q2 2026
Why Braze's Guidance Miss May Be a Gift for Investors
Braze's NASDAQ: BRZE September price crash looks like a buying opportunity, because the trigger for selling was questionable, and analyst activity has run counter to the move. The trigger was softer-t
Pomerantz Law Firm Announces The Filing of a Class Action Against Celsius Holdings, Inc. and Certain Officers - CELH
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Celsius Holdings, Inc. ("Celsius" or the "Company") (NASDAQ: CELH) and certain offic
Faruqi & Faruqi, LLP Urges Beta Bionics (BBNX) Investors to Seek Counsel Before November 3, 2026 Lead Plaintiff Deadline in the Securities Class Action
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Beta Bionics to Contact Him Directly to Discuss Their Options New York, New York--(N
Medicus Pharma reports positive Phase 2 data for SkinJect in skin cancer treatment
Medicus Pharma (NASDAQ:MDCX) said a completed Phase 2 study of its SkinJect therapy showed all 90 enrolled patients finished treatment without discontinuations, data the company says will guide its ne
ReconAfrica raises C$21.85M to fund Namibia sidetrack drilling
Reconnaissance Energy Africa Ltd (TSX-V:RECO, OTCQX:RECAF, FRA:0XD) said it plans to use proceeds from its newly closed C$21.85 million bought-deal offering to fund an open-hole horizontal sidetrack a
AGCO Corporation (AGCO) Presents at Jefferies Global Industrials Conference 2026 Transcript
AGCO Corporation (AGCO) Presents at Jefferies Global Industrials Conference 2026 Transcript
Nasdaq, Dow and S&P 500 Fall as U.S. Rates Rise
U.S. indices come under pressure as rising rates test key technical levels ahead of CPI.
Brace For A 5% 10Y Yield, And A Major Stock Market Correction
The 10Y Treasury yield is likely to exceed the 5% level as real rates and BE inflation both rise above the 2.5% level. The S&P500 has been largely ignoring the rising rates but a deep correction gets
Pfizer: Firing On All Cylinders
Pfizer (PFE) remains a strong buy as guidance is reaffirmed and raised, with acquired assets compounding at 18% operationally. PFE's pipeline strength is evident, especially in obesity (berobenatide)
EquipmentShare.com Inc. (EQPT) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
Philadelphia, Pennsylvania--(Newsfile Corp. - September 10, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against EquipmentShare.com Inc. (NASDAQ: EQPT) ("E
Why The Fed Must Cut Interest Rates
The S&P 500 (SPX) faces heightened uncertainty ahead of a pivotal FOMC meeting amid Treasury buybacks and global bond market vulnerabilities. Persistent inflation risks, driven by elevated oil prices
Chime Financial: A Buy, But Choose Your Entry Carefully
Chime Financial is a buy, driven by the Stride Bank acquisition and raised guidance, but valuation is stretched after an 86% three-month rally. CHYM now controls its own charter, removing sponsor bank
Waystar: Subscription Growth And AI Expansion Justify The Buy Position
Waystar Holding earns a buy rating for its compelling mix of 18% revenue growth, 34% subscription growth, and 42.8% adjusted EBITDA margin. WAY's expanding AI capabilities and the Iodine Software acqu
Flip Electronics Announces Authorized Distribution Partnership with Littelfuse
ALPHARETTA, Ga., Sept. 10, 2026 /PRNewswire/ -- Flip Electronics, a global authorized distributor specializing in hard-to-find, discontinued LTB, EOL, aged, and obsolete electronic components, today a
Higher Bond Yields Weigh On Valuations But Don't End The Bull Market
Rising oil prices and geopolitical risks, including the Iran conflict, are elevating energy costs and market uncertainty. Despite higher bond yields, strong demand for Treasuries and robust earnings g
Chewy: Modern Animal Acquisition, Strong NSPAC Growth, Cheap
Chewy delivered strong EBITDA and better-than-expected Q2 results, driven by organic sales growth and an expanding customer base. CHWY's strategic expansion into new verticals, notably veterinary care